Baricitinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Baricitinib, also known as Olumiant, is used to treat rheumatoid arthritis. It's a type of drug known as a Janus kinase JAK inhibitor. It works by blocking the action of Janus kinase enzymes, which are involved in the inflammation that causes the symptoms of rheumatoid arthritis.Baricitinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Baricitinib Nitroso Impurity 1 CAS NO: NA chemically represented as 2-(1-(Ethylsulfonyl)-3-(4-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile. Synchemia is the leading manufacturing and exporter of Baricitinib Nitroso Impurity 1.We supply Baricitinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143172 |
| CAS No | NA |
| Mol.F. | C7H5N3OS |
| Mol.Wt. | 179.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143173 |
| CAS No | NA |
| Mol.F. | C16H16N4O3 |
| Mol.Wt. | 312.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143174 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143175 |
| CAS No | NA |
| Mol.F. | C16H13N4O5 |
| Mol.Wt. | 341.30 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143176 |
| CAS No | NA |
| Mol.F. | C15H14N4OS |
| Mol.Wt. | 298.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143177 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143178 |
| CAS No | NA |
| Mol.F. | C18H18N4O6S |
| Mol.Wt. | 418.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143179 |
| CAS No | NA |
| Mol.F. | C16H16N4O4S |
| Mol.Wt. | 360.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143180 |
| CAS No | NA |
| Mol.F. | C26H26N6O5S2 |
| Mol.Wt. | 566.65 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143181 |
| CAS No | NA |
| Mol.F. | C17H18N4O5S |
| Mol.Wt. | 390.10 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143182 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.42 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143183 |
| CAS No | NA |
| Mol.F. | C12H11BrN2O2 |
| Mol.Wt. | 295.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143184 |
| CAS No | NA |
| Mol.F. | C12H10N2O2 |
| Mol.Wt. | 214.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143185 |
| CAS No | NA |
| Mol.F. | C17H14N4O3 |
| Mol.Wt. | 322.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143186 |
| CAS No | NA |
| Mol.F. | C13H18N4O3S |
| Mol.Wt. | 310.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143187 |
| CAS No | NA |
| Mol.F. | C10H16N4OS |
| Mol.Wt. | 240.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |